MedTrace Logo

Examining Parkinson's Disease-Related Retirement: Results of Turkey

NCT03779880 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2019-09-06

No results posted yet for this study

Summary

Although Parkinson Disease's (PD) is usually associated with an older patient population, 5% of patients are diagnosed at age 50 and 30% before 65 years of age. This shows that many patients with PD have diagnosed during the active study and have long periods of normal retirement. After the diagnosis of Parkinson's patients, the duration of leaving of employment vary between 0 and 25 years. It was found that patients' full-time working capacity decreased by up to 80% and they quitted earlier than the general population. The disability associated with PD is thought to be a factor in this situation. Nevertheless, the reasons for early retirement are not fully known and more information is needed on the specific problems of PD in order for patients to continue their career. The aim of our study is to examine the impact of Parkinson's disease on retirement and to contribute to Turkey's data. Patients with PD admitted to the Parkinson's disease outpatient clinic, which is the biggest clinic of Turkey about neurology, are included in the study. It is planned to meet with 75 patients on 31/12/2018 and to reach the end of the data collection phase.

Conditions

  • Parkinson Disease

Sponsors & Collaborators

  • Marmara University

    collaborator OTHER

  • Istanbul University

    collaborator OTHER

  • Istanbul Kültür University

    lead OTHER

Principal Investigators

  • Gamze Ertürk, GRAD ASST · Istanbul Kültür University

  • Semra Oğuz, ASST PROF · Marmara University

Eligibility

Min Age
30 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-02
Primary Completion
2018-12-31
Completion
2019-03-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03779880 on ClinicalTrials.gov